Needs Statement

Spasticity is a significant problem after TBI/stroke/spinal cord injury (SCI) and other UMN syndromes. Urban et. al. predicted spasticity after ischemic stroke was present in 42.6% of patients. Adams and Hicks describe 65-78% of patients with chronic SCI has symptoms of spasticity. Hibbard et.al. described 23.4 % of patients with traumatic brain injury have spasticity. Education and training specialists in all the treatment options of spasticity including therapy, medications, injection with botulinum toxins, and baclofen pumps is imperative in restoration of the individual back to health, function, and potentially employment.

Target Audience

This activity is intended for physical medicine and rehabilitation residents, fellows, faculty, and private practice physiatrists.

Learning Objectives

At the conclusion of the conference, participants should be able to:

• Describe the musculoskeletal anatomy of the neck, arm and leg as it relates to limb spasticity injection.
• Compare two types of guided injections that can be used for spasticity/dystonia.
• Discuss suspension and injection strategies for botulinum toxin.
• Demonstrate how to inject at least two of the 8 new muscles FDA approved for spasticity injection.
• Describe pain management of spasticity.

Educational Methods

Lecture ▪ Hands-on Workshop ▪ Question & Answer

Evaluation

Evaluation by questionnaire will address program content, presentation, and possible bias.